Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Ophthalmology Science
|
June 18, 2025
Next-Generation Sequencing-Based Molecular Profiling of Conjunctival Squamous Cell Carcinoma and Its Potential Application for Therapy
Hakan Demirci, Josh N Vo, Yi-Mi Wu, et al.
Acta Neuropathologica Communications
|
December 21, 2024
Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report
Josh N Vo, Andrea Franson, Sebastian M Waszak, et al.
Endocrine-Related Cancer
|
March 16, 2026
Adrenocortical Carcinoma as a Manifestation of Birt-Hogg Dubé Syndrome
Katherine I Wolf, Jenae Osborne, Antonio M Lerario, et al.
Cell
|
February 9, 2019
The Landscape of Circular RNA in Cancer
Josh N Vo, Marcin Cieslik, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2019
Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer
Steven Kregel, Rohit Malik, Irfan A Asangani, et al.
JCO Precision Oncology
|
December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes
Michelle F Jacobs, Sarah Austin, Andrea M Murad, et al.
The Journal of Investigative Dermatology
|
September 2, 2021
Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma
Paul W Harms, Monique E Verhaegen, Josh N Vo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Long-Read Haplotype Phasing Resolves Allelic Configuration as a Missing Layer of Precision Oncology
Josh N Vo, Yi-Mi Wu, Rui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
Kelly L Harms, Lili Zhao, Bryan Johnson, et al.
Nature Communications
|
June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Ophthalmology Science
|
June 18, 2025
Next-Generation Sequencing-Based Molecular Profiling of Conjunctival Squamous Cell Carcinoma and Its Potential Application for Therapy
Hakan Demirci, Josh N Vo, Yi-Mi Wu, et al.
Acta Neuropathologica Communications
|
December 21, 2024
Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report
Josh N Vo, Andrea Franson, Sebastian M Waszak, et al.
Endocrine-Related Cancer
|
March 16, 2026
Adrenocortical Carcinoma as a Manifestation of Birt-Hogg Dubé Syndrome
Katherine I Wolf, Jenae Osborne, Antonio M Lerario, et al.
Cell
|
February 9, 2019
The Landscape of Circular RNA in Cancer
Josh N Vo, Marcin Cieslik, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2019
Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer
Steven Kregel, Rohit Malik, Irfan A Asangani, et al.
JCO Precision Oncology
|
December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes
Michelle F Jacobs, Sarah Austin, Andrea M Murad, et al.
The Journal of Investigative Dermatology
|
September 2, 2021
Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma
Paul W Harms, Monique E Verhaegen, Josh N Vo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Long-Read Haplotype Phasing Resolves Allelic Configuration as a Missing Layer of Precision Oncology
Josh N Vo, Yi-Mi Wu, Rui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
Kelly L Harms, Lili Zhao, Bryan Johnson, et al.
Nature Communications
|
June 29, 2022
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, et al.
Page
of 2